Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01558479 · ClinicalTrials.gov registry record

The Parkinson's Genetic Research Study

A clinical trial of Parkinson's Disease, sponsored by University of Washington.

Recruiting
Registry status
5,000
Enrollment target
5
Study locations

NCT01558479 is a study of Parkinson's Disease that is actively recruiting participants, run by University of Washington. The registered enrollment target is 5,000 participants, above the 610-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (720% higher). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01558479, a study of Parkinson's Disease, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
5,000 participants
Enrollment target
5
Study locations

Study Summary

The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the National Institutes of Health. The coordinating center for PaGeR is located at the University of Washington and the VA Puget Sound Health Care System in Seattle.

Conditions Studied

Study Locations (5)

Washington

  • VA Puget Sound Health Care System - Seattle
  • University of Washington - Seattle

Georgia

  • Emory University/ Wesley Woods Health Center - Atlanta

Ohio

  • University of Cincinnati - Cincinnati

Oregon

  • Portland VA Medical Center - Portland

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2009-09
Est. Completion 2026-10-31

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01558479

The ClinicalTrials.gov registry entry for NCT01558479 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 610-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (720% higher). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01558479 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Washington, Georgia, Ohio.

Frequently Asked Questions

What is clinical trial NCT01558479 about?

NCT01558479 is a clinical study titled "The Parkinson's Genetic Research Study". The Parkinson's Genetic Research Study (PaGeR), headed by Dr. Cyrus Zabetian, is searching for genes that increase the risk of developing Parkinson's disease (PD) and related disorders. The study is a joint effort by neurologists and researchers across the United States and is sponsored by the Natio...

What is the current status of trial NCT01558479?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2009-09. Estimated completion is 2026-10-31.

What conditions does trial NCT01558479 study?

This clinical trial studies the following conditions: Parkinson's Disease.

Who is sponsoring clinical trial NCT01558479?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01558479 being conducted?

This trial has 5 study locations across Georgia, Ohio, Oregon, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.